DENVER, Feb. 21, 2019 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) a leading provider of kidney care services in the United States and 10 other countries, announced today that the company has been recognized as one of FORTUNE® Magazine's World's Most Admired Companies of 2019. This is the 12th consecutive year and 13th year overall the company has appeared on this list. In the Health Care: Medical Facilities category, DaVita ranked as the second most innovative company.
"As a health care community, we are continuously striving to improve and will always seek new ways to best serve our patients," said Kent Thiry, chairman and CEO of DaVita. "So we're both honored and humbled that these efforts are recognized on such a prestigious list."
DaVita has been acknowledged as a clinical leader in both of the Centers for Medicare & Medicaid Services quality assessment programs: the Five-Star Rating System and the Quality Incentive Program.
The company is invested in education and technology to support patients seeking treatment options for kidney disease, including kidney transplant and home dialysis—both of which allow greater independence and higher quality of life for most patients.
To compile its rankings, FORTUNE® surveys company executives, board members and industry analysts. Other factors include people management, use of corporate assets, quality of management, financial soundness, long-term investment and global competitiveness.
Learn how DaVita's award-winning culture helps deliver high quality patient care at DaVita.com/CSR.
About DaVita Inc.
DaVita is a health care provider focused on transforming care delivery to improve quality of life for patients around the globe. Through DaVita Kidney Care and the DaVita Medical Group, DaVita is pushing for what health care could be by delivering high-quality clinical outcomes and managing the total cost of care. DaVita is committed to bold, patient-centric care models, implementing the latest technologies and moving toward integrated care offerings for all. The company is the largest provider of kidney care services in the U.S. and has been a leader in clinical quality and innovation for 20 years. DaVita currently serves approximately 203,000 patients at 2,664 outpatient dialysis centers in the United States. The company also operates 241 outpatient dialysis centers located in 9 countries across Asia, Europe, the Middle East and South America. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. Since 2012, DaVita Medical Group has provided primary and ancillary care for approximately 1.7 million patients within medical groups and affiliated physician networks in California, Colorado, Florida, Nevada, New Mexico and Washington. To learn more about how DaVita is leading the health care evolution, please visit DaVita.com/About.
SOURCE DaVita Inc.